小鼠重组TRAIL

tnf相关的凋亡诱导配体

产品号 #(选择产品)

产品号 #78122_C

tnf相关的凋亡诱导配体

概述

TRAIL (TNF相关凋亡诱导配体)属于肿瘤坏死因子(TNF)超家族,与启动细胞凋亡有关。TRAIL有四个主要受体:两个死亡受体DR4和DR5,两个诱饵受体DcR1和DcR2。TRAIL与死亡受体结合,募集fas相关死亡结构域(FADD)并激活caspase 8和10,最终导致细胞凋亡(Pitti等人;Wiley等人;Zauli & Secchiero)。研究表明,缺乏TRAIL表达的小鼠在胸腺细胞凋亡和负选择方面存在缺陷,这些小鼠对自身免疫性疾病的易感性增加(Lamhamedi-Cherradi等)。

Subtype
Cytokines
 
Alternative Names
TL2, TNF-related apoptosis-inducing ligand, TNFSF10
 
Cell Type
T Cells
 
Species
Mouse
 
Area of Interest
Immunology
 
Molecular Weight
20 kDa
 
Purity
≥ 98%
 

Data Figures

(A) The biological activity of Mouse Recombinant TRAIL was tested by its ability to inhibit the proliferation of RPMI-8226 cells. Cell proliferation was measured using a fluorometric assay method. The EC50 is defined as the effective concentration of the growth factor at which cell proliferation is at 50% of maximum. The EC50 in the above example is less than 100 ng/mL. (B) 2 μg of Mouse Recombinant TRAIL was resolved with SDS-PAGE under reducing (+) conditions and visualized by Coomassie Blue staining.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
78122.1
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
78122.1
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Educational Materials (1)

更多信息

更多信息
Molecular Weight 20 kDa
Species Mouse
Alternative Names TL2, TNF-related apoptosis-inducing ligand, TNFSF10
Purity ≥ 98%
STEMCELL TECHNOLOGIES INC.’S QUALITY MANAGEMENT SYSTEM IS CERTIFIED TO ISO 13485. PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED.
版权 © 2025 STEMCELL Technologies 技术有限公司。保留所有权利。